Marzia Alberio

DPYD -Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: A Real-World Retrospective Study

Francesco Schettini, Alexandro Membrino, G Grazia, Aldo Caltavituro et autres

PURPOSE Metronomic chemotherapy with oral capecitabine + vinorelbine (Cape + VNL) provides synergistic cytostatic activity and antiangiogenic and immunomodulatory effects, potentially offering prolonged disease control with limited toxicity in HER2-negative metastatic breast cancer (MBC). However, efficacy in the real-world (RW) setting, especially …

es, it, jp (code pays fourni par la source)

Assessing the long-term prognostic ability of the 70 gene expression signature MammaPrint in an Italian single-center prospective cohort study of early-stage intermediate-risk breast cancer patients

Daniele Generali, Andrea Rocca, Carla Strina, Manuela Milani et autres

Purpose: The aim of this study was to assess the prognostic performance of the 70-gene signature, MammaPrint, in an Italian single-center prospective cohort of early-stage intermediate-risk breast cancer (BC) patients. Methods: A total of 195 eligible early BC cases were tested for …

it, nl (code pays fourni par la source)

P157 MammaPrint 8-year follow up results in patients with early breast cancer from a single-center Italian cohort study

Enrico Fiorino, F. Giudici, S. Aguggini, C. Strina et autres